Rreb1 binds and represses expression of the p16(Ink4a) promoter, and the development of pristane-induced plasma cell tumors in Balb/C mice is attributable to a polymorphism in this Rreb1 binding site (Zhang et al., 2003). The gene discussed is CDKN2A; the disease is plasma cell neoplasm.